Navigation path

Pharmaceuticals - Community Register


Community list of not active medicinal products for human use


Product information

Invented name: Filgrastim ratiopharm
Auth. number : EU/1/08/449
Active substance : filgrastim
ATC: Anatomical main group: L - Antineoplastic and immunomodulating agents
Therapeutic subgroup: L03 - Immunomodulating agents
Pharmacological subgroup: L03A - Immunostimulating agents
Chemical subgroup: L03AA - Cytokines
Chemical substance: L03AA02 - filgrastim
(See WHO ATC Index)
Indication: Reduction in the duration of neutropenia and the incidence of febrile neutropenia. Mobilisation of peripheral blood progenitor cells (PBPC). Severe congenital, cyclic, or idiopathic neutropenia, persistent neutropenia.
Marketing Authorisation Holder: ratiopharm GmbH
Graf-Arco-Straße 3, 89079 Ulm, Deutschland
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/09/2008 Centralised - Authorisation EMEA/H/C/824 (2008)5215 of 15/09/2008
21/02/2011 Centralised - Variation EMEA/H/C/824/IB/1/G
28/04/2011 Centralised - Withdrawal (2011)2947 of 20/04/2011